Delivery Order SPE2DB20D6036-SPE2DB24FC8KG
Award Date 4/23/24
Potential Completion Date 4/24/24
Potential Value $9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $4,338.52. The contract is a delivery order with a firm fixed price structure, and has a period of performance ending on May 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract...
- This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $61,602.41 and an ultimate completion date of December 22, 2023. It was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed-price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open...
- This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets in quantities of 500 to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, on February 29, 2024, with a ceiling value of $3,774.68 and an ultimate completion date of March 1, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Bupropion HCL XL 150 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the corporate office of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $15,589.52. The contract is a delivery order with a firm fixed price, and the period of performance extends through April 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,543,508 units of Bupropion HCL XL 300 mg tablets. The contract has a ceiling value of $13,933.62 and is a firm fixed-price delivery order that will run through May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The $12,760.48 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The $23,494.99 firm fixed-price delivery order is for the supply of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of April 19, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Bupropion HCL XL 300mg tablets. The contract has a ceiling value of $11,557.69 and a period of performance through April 24, 2024. It is a Firm Fixed Price contract, without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award was issued by the U.S. Department of Defense's Medical Supply Chain agency to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Bupropion HCL XL 300 mg tablets. The firm-fixed-price delivery order, valued at $44,120.07, has an ultimate completion date of April 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...